Built around one studied dose.
HarmonyMD exists because the largest cacao flavanol trial in history — COSMOS, published in the American Journal of Clinical Nutrition in 2022 — used a dose nobody could buy. So we built it. One ritual. One jar. One standard.
Est. 2025
The dose nobody sold.
The COSMOS trial randomized 21,442 adults to daily cacao flavanols for 3.6 years and reported a 27% reduction in cardiovascular death. The trial dose: 500 mg cacao flavanols with 80 mg standardized (–)-epicatechin, daily. CCV-3® is built at 1,200 mg flavanols with 600 mg epicatechin — 2.4× the trial flavanol dose and 7.5× the epicatechin.
Then we walked the supplement aisle. Most cacao products deliver 80 to 200 mg of flavanols per scoop. The gap between what's available and what the trial measured is roughly ten-fold. HarmonyMD was built to close that gap. One scoop. The studied dose. Every batch.

Est. 2025 · CCV-3® built to the COSMOS dose
Cacao is not cacao.
Cacao is what survives industrial dutching, alkalization, and high-heat roasting. Processes that strip the flavanols the 2022 trial measured. What remains tastes like chocolate and behaves like sugar.
“Cacao, not cacao. Built at the dose the science actually used, in the form the plant actually produces it.”
Cacao is the unprocessed seed. Fermented at the farm. Sun-dried. Cold-milled. The 1,200 milligram CCV-3® complex is built from three premium cacao cultivars chosen for their flavanol density: from the premium cacao, from Cacao, and a heritage grown small-batch. The blend compensates for what any single source cannot deliver consistently.
This is the distinction the supplement aisle erased. We are bringing it back, at the dose the science actually used, in the form the plant actually produces it.
CCV-3®. Three cultivars. One studied dose.
Most flavanol products on the market list one source and a marketing-grade dose. CCV-3® is built around the dose the published trials used. That dose is non-negotiable. The blend carries it.
Built around the largest cacao trial ever run.
COSMOS is the 21,442-adult Cocoa Supplement and Multivitamin Outcomes Study, published in the American Journal of Clinical Nutrition in 2022. It followed participants for 3.6 years on daily cacao flavanol supplementation. The pre-specified secondary endpoint was the one HarmonyMD is built around.
Most cardiovascular nutrition products are sold on lifestyle association. HarmonyMD is sold on a single line of evidence: the dose the trial used and the blend that carries it.
For people who already read labels.
- For people who already track their numbers.
- For people who have stopped buying mass-market wellness.
- For people who want the dose the trial used, not the dose the supplement aisle is willing to sell.
A daily practice. Not a purchase. The COSMOS dose, on the kitchen counter, every morning.
Built to one standard. Every batch.
A single source. A single dose. A single way to make it.
Begin the daily ritual.
Subscribe and receive a fresh jar every 30 days. The COSMOS dose, on the kitchen counter, every morning.